Caregen Co Ltd
214370
Company Profile
Business description
Caregen Co Ltd is in the business of research and marketing of Biomimetic peptides and Growth factors. It also offers customized Biomimetic Peptides and toll manufacturing services. The firm's business areas include research and development, production and supply of active ingredients, production and global distribution of Cosmeceuticals and Medical devices and global operation of hair care center. The company's products include CG-Illugen, CG-Nugenerin, CG-Fibrofillin, CG-EGF etc.
Contact
46-38, Ls-Ro 91beon-Gil
Dongan-Gu
Gyeonggi-Do
Anyang-Si431848
KORT: +82 314209200
Sector
Consumer Defensive
Stock type
Defensive
Industry
Household & Personal Products
Fiscal Year End
31 December 2026
Employees
200
Stocks News & Analysis
stocks
SK Hynix Earnings: We raise fair value estimate on strong AI memory demand
Shares jumped 9% after earnings, as stronger AI memory prices boosted the chipmaker’s outlook.
stocks
Meta shares are down 12% since earnings. Is the stock a buy?
Concerns about equity sales to finance AI investments have pressured shares.
stocks
SpaceX earnings: We raise our fair value estimate on scaling data centres, but is the stock a buy?
AI data center revenue is growing fast, but questions about durability remain.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,012.60 | 41.20 | 0.46% |
| CAC 40 | 7,970.00 | 83.04 | 1.05% |
| DAX 40 | 26,039.68 | 335.66 | 1.31% |
| Dow JONES (US) | 52,342.62 | 132.48 | -0.25% |
| FTSE 100 | 10,722.07 | 27.57 | 0.26% |
| HKSE | 22,958.65 | 136.18 | -0.59% |
| NASDAQ | 26,184.72 | 365.13 | -1.38% |
| Nikkei 225 | 64,659.47 | 705.28 | 1.10% |
| NZX 50 Index | 13,710.17 | 18.84 | 0.14% |
| S&P 500 | 7,720.22 | 23.76 | -0.31% |
| S&P/ASX 200 | 8,891.80 | 44.50 | 0.50% |
| SSE Composite Index | 3,651.43 | 30.04 | -0.82% |